The Lancet. Infectious diseases 2018 Sep ; 18(9); 947-948. doi: 10.1016/S1473-3099(18)30465-1. Epub 2018 08 28
Publications
Micro-Hotspots of Risk in Urban Cholera Epidemics.
Abstract
Targeted interventions have been delivered to neighbors of cholera cases in major epidemic responses globally despite limited evidence for the impact of such targeting.
The Journal of infectious diseases 2018 Aug 24; 218(7); 1164-1168. doi: 10.1093/infdis/jiy283. Epub 2018 11 14
Voluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness.
Abstract
Background: In southwest Kenya, the prevalence of human immunodeficiency virus (HIV) infection is about 25%.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2018 Aug 16; 67(5); 719-726. doi: 10.1093/cid/ciy173. Epub 2018 11 14
A dynamic model of transmission and elimination of peste des petits ruminants in Ethiopia.
Abstract
Peste des petits ruminants (PPR), a devastating viral disease of sheep and goats, has been targeted by the global community for eradication within the next 15 years.
Proceedings of the National Academy of Sciences of the United States of America 2018 08 14; 115(33); 8454-8459. doi: 10.1073/pnas.1711646115. Epub 2018 07 27
control
elimination
eradication
mathematical model
vaccination
Acceptability and Utilization of Three Nutritional Supplements during Pregnancy: Findings from a Longitudinal, Mixed-Methods Study in Niger.
Abstract
Nutritional status in pregnancy is a key determinant of birth outcomes. In low-income countries, maternal diets are often limited, and daily nutrient supplements are recommended to fill nutrient gaps.
Nutrients 2018 Aug 12; 10(8); doi: 10.3390/nu10081073. Epub 2018 08 12
Niger
diet
maternal nutrition
pregnancy outcomes
prenatal supplement
qualitative methods
Depression and Suicidal Ideation Among HIV-Infected Adults Receiving Efavirenz Versus Nevirapine in Uganda: A Prospective Cohort Study.
Abstract
Background: Evidence regarding potential adverse neuropsychiatric effects of efavirenz is conflicting, and data from sub-Saharan Africa, where 70% of persons living with HIV (PLHIV) reside and efavirenz is used as first-line therapy, a
Annals of internal medicine 2018 Aug 07; 169(3); 146-155. doi: 10.7326/M17-2252. Epub 2018 06 26
Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting.
Abstract
The Xpert MTB/RIF assay is a major advance for diagnosis of tuberculosis (TB) in high-burden countries but is limited in children by their difficulty to produce sputum.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2018 Aug ; 37(8); 1465-1473. doi: 10.1007/s10096-018-3272-0. Epub 2018 05 08
Childhood tuberculosis
Sputum
Stool
Xpert MTB/RIF
Evaluation of the SD bioline cholera rapid diagnostic test during the 2016 cholera outbreak in Lusaka, Zambia.
Abstract
OBJECTIVE: To assess the performance of the SD Bioline Cholera Ag O1/O139 rapid diagnostic test (RDT) compared to a reference standard combining culture and PCR for the diagnosis of cholera cases during an outbreak.
Tropical medicine & international health : TM & IH 2018 Aug ; 23(8); 834-840. doi: 10.1111/tmi.13084. Epub 2018 06 29
cholera
choléra
diagnostic accuracy
outbreak
précision diagnostique
rapid diagnostic test
test de diagnostic rapide
épidémie
Distribution and Performance of Cardiovascular Risk Scores in a Mixed Population of HIV-Infected and Community-Based HIV-Uninfected Individuals in Uganda.
Abstract
BACKGROUND: The utility and validity of cardiovascular diseases (CVD) risk scores are not well studied in sub-Saharan Africa.
Journal of acquired immune deficiency syndromes (1999) 2018 Aug 01; 78(4); 458-464. doi: 10.1097/QAI.0000000000001696. Epub 2018 11 14
Pharmacokinetics of efavirenz in patients on antituberculosis treatment in high human immunodeficiency virus and tuberculosis burden countries: A systematic review.
Abstract
AIMS: Efavirenz (EFV) and rifampicin-isoniazid (RH) are cornerstone drugs in human immunodeficiency virus (HIV)-tuberculosis (TB) coinfection treatment but with complex drug interactions, efficacy and safety challenges.
British journal of clinical pharmacology 2018 Aug ; 84(8); 1641-1658. doi: 10.1111/bcp.13600. Epub 2018 05 22
HIV/AIDS < infectious diseases
adverse drug reactions
antiretrovirals < infectious diseases
genetics and pharmacogenetics
pharmacokinetics